Haemonetics Other Current Assets 2010-2025 | HAE
Haemonetics other current assets from 2010 to 2025. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Haemonetics Annual Other Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Haemonetics Quarterly Other Current Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-12-31 | |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.417B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.138B | 28.03 |
| Boston Scientific (BSX) | United States | $152.812B | 38.26 |
| Stryker (SYK) | United States | $145.981B | 30.52 |
| EssilorLuxottica (ESLOY) | France | $128.807B | 0.00 |
| Medtronic (MDT) | Ireland | $107.246B | 15.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.937B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.673B | 27.10 |
| ResMed (RMD) | United States | $35.644B | 26.77 |
| GE HealthCare Technologies (GEHC) | United States | $32.281B | 15.33 |
| Agilent Technologies (A) | United States | $30.991B | 20.47 |
| Terumo (TRUMY) | Japan | $28.175B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.624B | 16.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.817B | 12.09 |
| Insulet (PODD) | United States | $18.083B | 70.99 |
| Baxter (BAX) | United States | $16.011B | 11.95 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.408B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.962B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.751B | 22.82 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 14.04 |
| Prestige Consumer Healthcare (PBH) | United States | $4.312B | 19.21 |
| Perrigo (PRGO) | Ireland | $3.684B | 9.34 |
| ICU Medical (ICUI) | United States | $3.516B | 25.93 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.012B | 25.03 |
| QuidelOrtho (QDEL) | United States | $2.459B | 16.96 |
| GN Store Nord (GNNDY) | Denmark | $2.020B | 16.73 |
| LeMaitre Vascular (LMAT) | United States | $1.841B | 41.16 |
| AtriCure (ATRC) | United States | $1.544B | 0.00 |
| Neogen (NEOG) | United States | $1.300B | 16.64 |
| Green Thumb Industries (GTBIF) | United States | $1.234B | 27.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.162B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.130B | 11.47 |
| BioLife Solutions (BLFS) | United States | $1.062B | 0.00 |
| InMode (INMD) | Israel | $0.990B | 9.06 |
| Phibro Animal Health (PAHC) | United States | $0.901B | 11.53 |
| Evolus (EOLS) | United States | $0.651B | 0.00 |
| CeriBell (CBLL) | United States | $0.616B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.592B | 0.00 |
| Owens & Minor (OMI) | United States | $0.540B | 4.48 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.405B | 0.00 |
| Surmodics (SRDX) | United States | $0.389B | 0.00 |
| Omeros (OMER) | United States | $0.368B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.356B | 13.11 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.267B | 47.50 |
| Verano Holdings (VRNOF) | United States | $0.266B | 0.00 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.256B | 11.63 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| Quanterix (QTRX) | United States | $0.214B | 0.00 |
| Biote (BTMD) | United States | $0.205B | 5.75 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.25 |
| TriSalus Life Sciences (TLSI) | United States | $0.167B | 0.00 |
| Brainsway (BWAY) | Israel | $0.167B | 52.18 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.33 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Exagen (XGN) | United States | $0.111B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.080B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.078B | 10.91 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 58.50 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.74 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |